Medical

RACGP warns of higher costs for patients needing ECGs

Health Industry Hub | July 27, 2020 |
[Total: 1    Average: 4/5]

Medical News: The Royal Australian College of General Practitioners (RACGP) is warning that patients who need electrocardiograms (ECGs) will likely face higher costs due to imminent changes to the Medicare Benefits Schedule (MBS).

The changes to MBS items for ECGs, due to come into force on August 1st, will significantly reduce patient rebates for ECGs in general practice, effectively restricting these services to consultant physicians and other specialists.

Under the changes, patients will only be eligible for item 11707 for ECG tracing in general practice, and will no longer be able to claim for tracing and reporting. This will result in a substantially lowered patient rebate.

RACGP President Dr Harry Nespolon said the changes would likely result in higher costs and inconvenience for patients.

“The RACGP is deeply disappointed at the decision to reduce patient rebates for ECGs in general practice – these changes are likely to hurt patients through higher costs and inconvenience.

“The decision completely fails to recognise the work GPs do with ECGs – we perform interpretation, report results in patient records and determine actions that need to be taken, very often without needing to refer patients to another specialist for interpretation and reporting.

“The changes mean patients will more likely have to go to more expensive specialists for these services and face higher out of pocket costs.

“The RACGP advocated strongly against these changes for good reason. Chronic conditions requiring ECGs and associated care like heart problems are increasing in Australia.

“Primary care is the most cost effective way of providing high-quality care for such patients – the government should be investing in primary care to keep patients out of the hospital system, instead we are seeing this ripped away.”


About the author

About the author

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nam luctus finibus scelerisque. Nunc bibendum ipsum sed augue fringilla fringilla. Nullam at consectetur leo. Praesent viverra rutrum porta. Quisque vitae mi vel purus vulputate tincidunt. Class aptent taciti sociosqu ad litora torquent per conubia nostra, per inceptos himenaeos. Suspendisse et mi quis nisi rhoncus feugiat at ac tellus. Sed aliquam sodales nulla ac auctor. Sed pretium lobortis purus accumsan ullamcorper. Phasellus sodales vel odio in lobortis. Duis maximus sagittis bibendum. Interdum et malesuada fames ac ante ipsum primis in faucibus. Nunc dictum tincidunt ipsum in vestibulum. Donec ut sem consectetur, aliquam quam vitae, pharetra orci. Nam egestas non velit eu rhoncus. Duis congue neque non lacus tincidunt porta. Vestibulum ultricies pulvinar sem, molestie congue dui aliquet non.
  • Ut imperdiet leo id lorem fermentum consectetur.
  • Ut vitae orci et dui varius tincidunt.
  • Ut id magna non libero vestibulum pharetra ac faucibus nulla.
Aliquam erat volutpat. Vestibulum vitae varius diam. Nulla eget congue ante. Nunc ullamcorper sagittis augue vel dictum. Mauris finibus nibh ut pulvinar auctor. Vestibulum ut faucibus nisi. Orci varius natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Quisque porta tortor ac justo malesuada elementum. Nulla tellus ante, cursus nec ex sit amet, suscipit bibendum arcu. Duis posuere orci dui, et mollis enim dictum at. Sed ullamcorper, sapien ut vulputate viverra, sem purus porttitor tellus, nec mattis mauris ligula sed risus. Nulla sagittis id ipsum eu mattis. Link to full profile

Marketing & Strategy

Marketing Pharma Biotech Healthcare - PRIME Awards 2020 finalists announced

PRIME Awards 2020 finalists announced

Health Industry Hub | August 7, 2020 |

The finalists for PRIME Awards 2020 have been named, with winners to be announced via a virtual ceremony on Thursday […]

More


News & Trends - Pharmaceuticals

Pharma News - New Ventolin inhalers with dose counter reimbursed on the PBS

New Ventolin inhalers with dose counter reimbursed on the PBS

Health Industry Hub | August 7, 2020 |

Pharma News: GSK Australia is pleased to announce that a dose counter has been added to VENTOLIN (salbutamol sulfate) metered […]

More


News & Trends - Medical Technology

MedTech News - Siemens Healthineers to acquire Varian in $16.4bn deal

Siemens Healthineers to acquire Varian in $16.4bn deal

Health Industry Hub | August 5, 2020 |

MedTech News: Siemens Healthineers shall acquire Varian Medical Systems for approximately USD$16.4 billion. Since 2012, Siemens Healthineers and Varian have […]

More


News & Trends - Pharmaceuticals

Pharma News - New anti-cancer drug for prostate cancer

New anti-cancer drug for prostate cancer

Health Industry Hub | August 5, 2020 |

Pharma News: A new anti-cancer drug for prostate cancer overcomes the twin problems plaguing researchers for decades. It halts metastasis […]

More